Orthofix Medical Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Orthofix Medical Inc. (OFIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $700.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2016-02-29
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was $700.00K, a 66.67% decline from fiscal 2014.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $2.10M, a 425.00% increase from fiscal 2013.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was $400.00K, a 94.44% decline from fiscal 2012.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2012 was $7.20M, a 71.43% increase from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2015-12-31 | $700.00K 10-K · filed 2016-02-29 |
| 2014-12-31 | $2.10M 10-K · filed 2016-02-29 |
| 2013-12-31 | $400.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $7.20M 10-K · filed 2015-04-29 |
| 2011-12-31 | $4.20M 10-K/A · filed 2015-03-31 |
| 2010-12-31 | $3.00M 10-K/A · filed 2014-03-24 |
| 2009-12-31 | $100.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |